The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States.
Clin Lab Med
; 42(2): 147-160, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2130435
ABSTRACT
SARS-CoV-2 was identified and diagnostic methods developed at an impressive speed due in great part to the wider use of molecular methods in 2019 compared with 2002 during the SARS pandemic. The development of rapid and novel molecular diagnostic assays, leveraging of the high adaptability of molecular tests, and the integration of SARS-CoV-2 genotyping into public health, clinical, and research laboratories have been some of the successes in SARS-CoV-2 molecular testing. The main challenges are related to regulatory hurdles, supply chain constraints, and laboratory preparation.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
SARS-CoV-2
/
COVID-19
Tipo de estudio:
Estudios diagnósticos
/
Estudio observacional
/
Estudio pronóstico
Límite:
Humanos
País/Región como asunto:
America del Norte
Idioma:
Inglés
Revista:
Clin Lab Med
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS